Xizang Weixinkang Pharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 84.54 million yuan, a year-on-year decrease of 10.93%
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Xizang Weixinkang Pharmaceutical disclosed its first-quarter report for 2025. During the reporting period, the company achieved revenue of 296 million yuan, a year-on-year decrease of 6.93%; net profit attributable to the parent company was 84.54 million yuan, a year-on-year decrease of 10.93%; and net profit excluding non-recurring gains and losses was 74.35 million yuan, a year-on-year increase of 31.10%. Basic earnings per share were 0.20 yuan
According to the Zhitong Finance APP, Xizang Weixinkang Pharmaceutical (603676.SH) disclosed its first-quarter report for 2025. During the reporting period, the company achieved revenue of 296 million yuan, a year-on-year decrease of 6.93%; net profit attributable to the parent company was 84.54 million yuan, a year-on-year decrease of 10.93%; and net profit excluding non-recurring gains and losses was 74.35 million yuan, a year-on-year increase of 31.10%. The basic earnings per share were 0.20 yuan